3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Neoplasms
3
Trigger Finger Disorder
1
Stomach Neoplasms
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Nose Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Kidney Neoplasms
1
Ganglion Cysts
1
Esthesioneuroblastoma, Olfactory
1
Dupuytren Contracture
1
De Quervain Disease
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Carpal Tunnel Syndrome
1
Cachexia
1
Biliary Tract Neoplasms
1
Interventions
Megestrol Acetate
4
Mirtazapine
2
ostarine
1
nabiximols
1
clazakizumab
1
anamorelin
1
Sodium Chloride
1
Physical Therapy Modalities
1
Omacor
1
Olanzapine
1
Nutrition Assessment
1
Megestrol
1
Infliximab
1
Ibuprofen
1
Gemcitabine
1
Flurandrenolone
1
Fecal Microbiota Transplantation
1
Cyproheptadine
1
Clarithromycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Cachexia
×
Ibuprofen
×
Clear all
NCT04907864
2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2
Unknown
112 enrolled